RxDoctor Payments Data

Timothy Graham, DPM

Podiatrist · Taylorville, ILNPI 1134213119

Payments from drug & device makers

What this record shows

This record is dominated by gifts: $44,100 of the $70,040 with a category attached, or 63.0%. Smith+Nephew accounts for 63.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $44,100 and has fallen 100.0% since, to $20 in 2025. Among podiatrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$70,040in general payments, 2019–2025

Across 26 payments — averaging $2693.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$44K
  • Reddress USA, Inc.$26K

What the payments were for

  • Consulting fees$25,92037%
  • Food & beverage$200%
  • Gifts$44,10063%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew2$44,120
Reddress USA, Inc.24$25,920

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,040 in reported general payments places this provider in the 95th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$111,913
Medicare patients
238
Services billed
1,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SsdSilver Sulfadiazine14$84
Ciprofloxacin Hcl13$45
Silver Sulfadiazine12$45
Hydrocortisone11$42

Paid to pharmacies, not to this prescriber.

Other podiatrist in Taylorville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →